In a potential game changer for patients with type 2 diabetes, a team of researchers at the Diabetes, Obesity, and Metabolism Institute (DOMI) at the Icahn School of Medicine at Mount Sinai has identified a therapeutic target for the preservation and regeneration of beta cells (β cells)—cells in the pancreas that produce and distribute insulin. The discovery could prevent insulin resistance and thus have significant benefits for millions of people worldwide. The results of the study were published in Nature Communications in July.
You may also be interested in:
Researchers have successfully engineered human immune cells to model an infection common among immunocompromised people in a discovery that paves the way for new drug [...]
All children born before full term are more likely to have poorer attainment during primary school compared with children born full term (39–41 weeks), but [...]
A new study published in the Journal of Eating Disorders found that, in course of a year, over half of men, women, and transgender or [...]